SCHEMBL205804

SCHEMBL205804

Cc1cc(O)cc(C)c1-c1cccc(C=O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.53
TRIM24 O15164 1/20 0.46
TRIM33 Q9UPN9 1/20 0.46
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
UNG P13051 1/20 0.41
ALDH1A1 P00352 2/20 0.40
MAOA P21397 2/20 0.39
MAOB P27338 2/20 0.39
MEN1 O00255 1/20 0.38
HSP90AA1 P07900 1/20 0.38
KMT2A Q03164 1/20 0.38
ATM Q13315 1/20 0.38
FFAR1 O14842 1/20 0.38
KDM4E B2RXH2 1/20 0.37
PTGS2 P35354 1/20 0.37
RAB9A P51151 1/20 0.37
ESR2 Q92731 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1974835 0.86 BRD4 (0.55) BRD4TRIM24TRIM33CA12CA1
SCHEMBL1745297 0.85 BRD4 (0.58) BRD4TRIM24TRIM33CA12CA1
SCHEMBL203685 0.80 BRD4 (0.47) BRD4TRIM24TRIM33CA12CA1
SCHEMBL2911266 0.80 ESR2 (0.59) BRD4TRIM24TRIM33CA12CA1
SCHEMBL24028046 0.79 MAOA (0.39) BRD4TRIM24TRIM33CA12CA1
SCHEMBL205798 0.79 BRD4 (0.53) BRD4TRIM24TRIM33CA12CA1
SCHEMBL12577722 0.79 BRD4 (0.49) BRD4TRIM24TRIM33CA12CA1
SCHEMBL2022257 0.79 BRD4 (0.49) BRD4TRIM24TRIM33CA12CA1
SCHEMBL16347706 0.79 BRD4 (0.46) BRD4TRIM24TRIM33CA12CA1
SCHEMBL204011 0.79 BRD4 (0.46) BRD4TRIM24TRIM33CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105143181-B Ternary and ring carboxylic acid derivative, its preparation method and its application in medicine 四川海思科制药有限公司 2017-12-26 CN disclosed
US-20160200734-A1 CARBOXYLIC ACID COMPOUNDS IN TREATMENT OF DIABETES MELLITUS KANG, XINSHAN (CN) 2016-07-14 US disclosed
US-20160200734-A1 CARBOXYLIC ACID COMPOUNDS IN TREATMENT OF DIABETES MELLITUS KANG, XINSHAN (CN) 2016-07-14 US disclosed
US-20160200734-A1 CARBOXYLIC ACID COMPOUNDS IN TREATMENT OF DIABETES MELLITUS KANG, XINSHAN (CN) 2016-07-14 US disclosed
EP-3036237-A1 CARBOXYLIC ACID COMPOUNDS IN TREATMENT OF DIABETES MELLITUS Fujian Haixi Pharmaceuticals Co. Ltd (CN) 2016-06-29 EP disclosed
CN-105246875-A Indane derivative, preparation method therefor, and pharmaceutical application thereof SICHUAN HAISCO PHARMACEUTICAL CO LTD 2016-01-13 CN disclosed
CN-105143181-A Triadic fused cyclic carboxylic acids derivatives, preparation method therefor and pharmaceutical use thereof SICHUAN HAISCO PHARMACEUTICAL CO LTD 2015-12-09 CN disclosed
US-9139548-B2 Polycyclic derivatives, preparation process and pharmaceutical use thereof JIANGSU HENGRUI MEDICINE CO., LTD. (CN) 2015-09-22 US disclosed
US-9139548-B2 Polycyclic derivatives, preparation process and pharmaceutical use thereof JIANGSU HENGRUI MEDICINE CO., LTD. (CN) 2015-09-22 US disclosed
CN-104592211-A Biphenyl compound and use thereof GUANGDONG HEC PHARMACEUTICAL 2015-05-06 CN disclosed
US-20080269220-A1 Aminophenylpropanoic Acid Derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-10-30 US disclosed
US-20080269220-A1 Aminophenylpropanoic Acid Derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-10-30 US disclosed
EP-1916234-A1 CYCLOPROPANECARBOXYLIC ACID COMPOUND Takeda Pharmaceutical Company Limited (JP) 2008-04-30 EP disclosed
EP-1916234-A1 CYCLOPROPANECARBOXYLIC ACID COMPOUND Takeda Pharmaceutical Company Limited (JP) 2008-04-30 EP disclosed
US-20070149608-A1 3-(4-Benzyloxyphenyl) propanoic acid derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-06-28 US disclosed
US-20070149608-A1 3-(4-Benzyloxyphenyl) propanoic acid derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-06-28 US disclosed
US-20070149608-A1 3-(4-Benzyloxyphenyl) propanoic acid derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-06-28 US disclosed
EP-1726580-A1 AMINOPHENYLPROPANOIC ACID DERIVATIVE Takeda Pharmaceutical Company Limited (JP) 2006-11-29 EP disclosed
US-20060258722-A1 Condensed ring compound TAKEDA PHARMACEUTICAL COMPANY., LTD. (JP) 2006-11-16 US disclosed
EP-1630152-A1 CONDENSED RING COMPOUND Takeda Pharmaceutical Company Limited (JP) 2006-03-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160200734-A1 CARBOXYLIC ACID COMPOUNDS IN TREATMENT OF DIABETES MELLITUS GPR119, GLP1R, INSR BRD4 2917/4885TRIM24 3506/4885TRIM33 3875/4885
US-20070149608-A1 3-(4-Benzyloxyphenyl) propanoic acid derivatives GPR119, GPR55, GLP1R BRD4 1422/4885TRIM24 2107/4885TRIM33 2060/4885
US-20080269220-A1 Aminophenylpropanoic Acid Derivative GPR119, GPR55, GPR65 BRD4 2707/4885TRIM24 2547/4885TRIM33 1696/4885
US-20060258722-A1 Condensed ring compound GPR119, GLP1R, GCGR BRD4 277/4885TRIM24 1608/4885TRIM33 1268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.